CompletedPhase 2/3

High Quality Fluorescent Cholangiography

China168 participantsStarted 2023-08-04

Plain-language summary

The goal of this randomized controlled trial is to compare the quality of extrahepatic biliary fluorescent visualization under two injection protocols to optimize extrahepatic biliary cholangiography.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. The patient has indications for cholecystectomy and requires laparoscopic treatment；
✓. No biliary obstruction or cholestasis was found during preoperative examination；3.Volunteer to participate in this clinical trial and sign written informed consent.

Exclusion criteria

✕. Patients who require emergency surgical treatment；
✕. Patients with malignant tumors of the biliary tract；
✕. Patients with a history of abdominal surgery；
✕. Patients who are allergic to indocyanine green or iodine contrast agents；5.Patients participating in one or more other clinical trials simultaneously；
✕.Patients who have received medication that affects bile excretion within 2 weeks before surgery； 7.Other situations that have been judged unsuitable for inclusion by researchers.

What they're measuring

Common bile duct-to-liver fluorescence intensity ratio

Timeframe: Intraoperative (The beginning of the surgery)

Trial details

NCT IDNCT05926856

SponsorZhujiang Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-11

View on ClinicalTrials.gov More Extrahepatic Biliary Tree Injury trials